Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Data (Unaudited) (Tables)

v3.19.1
Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Mar. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Summary of Company's Unaudited Quarterly Results

A capsule summary of the Company's unaudited quarterly results for fiscal 2019 and fiscal 2018 is presented below:

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

 

Total

 

Year ended March 31, 2019

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Year

 

Net sales

 

$

29,551

 

 

$

21,441

 

 

$

17,198

 

 

$

23,641

 

 

$

91,831

 

Gross profit

 

 

7,142

 

 

 

6,227

 

 

 

3,742

 

 

 

4,798

 

 

 

21,909

 

Net (loss) income

 

 

2,323

 

 

 

1,827

 

 

 

95

 

 

 

(4,553

)

(1)

 

(308

)

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

.24

 

 

$

.19

 

 

$

.01

 

 

$

(0.46

)

 

$

(0.03

)

Diluted

 

$

.24

 

 

$

.19

 

 

$

.01

 

 

$

(0.46

)

 

$

(0.03

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market price range of common stock

 

$20.75-27.51

 

 

$22.55-28.98

 

 

$19.48-28.73

 

 

$19.00-24.9

 

 

$19.00-28.98

 

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

 

Total

 

Year ended March 31, 2018

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Year

 

Net sales

 

$

20,851

 

 

$

17,224

 

 

$

17,281

 

 

$

22,178

 

 

$

77,534

 

Gross profit

 

 

4,778

 

 

 

3,741

 

 

 

3,496

 

 

 

4,960

 

 

 

16,975

 

Net (loss) income

 

 

935

 

 

 

10

 

(2)

 

(11,622

)

(2)

 

833

 

(2)

 

(9,844

)

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

.10

 

 

$

 

 

$

(1.19

)

 

$

.09

 

 

$

(1.01

)

Diluted

 

$

.10

 

 

$

 

 

$

(1.19

)

 

$

.09

 

 

$

(1.01

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market price range of common stock

 

$19.31-24.03

 

 

$18.78-21.25

 

 

$17.97-22.53

 

 

$19.76-23.25

 

 

$17.97-24.03

 

 

(1)  In the fourth quarter of fiscal 2019, the Company recorded goodwill and other impairment losses of $6,449 related to the commercial nuclear utility business that was held for sale at March 31, 2019.  As a result, net income in the fourth quarter of fiscal 2019 includes the impairment loss net of an income tax benefit of $1,129.    

 

(2)   In the second quarter of fiscal 2018, the Company recognized restructuring charges of $316.  As a result, net income in the second quarter includes the restructuring charge net of an income tax benefit of $92.  In the third quarter of fiscal 2018, the Company recorded a loss from the impairment of goodwill and intangible assets of $14,816, other charges related to the commercial nuclear utility business of $280 and an income tax benefit related to the Tax Act.  As a result, net income in the third quarter of fiscal 2018 includes the impairment loss net of an income tax benefit of $2,802, other charges related to the commercial nuclear utility business net of an income tax benefit of $87 and an income tax benefit of $577 related to the Tax Act.  In the fourth quarter of fiscal 2018, an additional income tax benefit of $209 was recorded related to the Tax Act.